V.M. Robinson

Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial

2017 | Lékařská fakulta v Hradci Králové

Publikace